$2.76 Billion is the total value of BVF INC/IL's 83 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 18.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GHRS | GH RESEARCH PLCordinary shares | $216,389,000 | +5.8% | 9,275,158 | 0.0% | 7.85% | -1.6% | |
| KYMR | KYMERA THERAPEUTICS INC | $201,940,000 | +8.1% | 3,180,658 | 0.0% | 7.33% | +0.6% | |
| RCUS | Buy | ARCUS BIOSCIENCES INC | $137,520,000 | +22.1% | 3,398,067 | +5.2% | 4.99% | +13.6% |
| MRUS | New | MERUS N V | $131,495,000 | – | 4,135,071 | +100.0% | 4.77% | – |
| PTGX | Sell | PROTAGONIST THERAPEUTICS INC | $124,890,000 | +80.6% | 3,651,759 | -6.4% | 4.53% | +68.1% |
| XENE | Buy | XENON PHARMACEUTICALS INC | $102,765,000 | +327.9% | 3,289,540 | +109.3% | 3.73% | +298.1% |
| RPTX | Buy | REPARE THERAPEUTICS INC | $102,471,000 | +4.9% | 4,858,761 | +30.5% | 3.72% | -2.4% |
| RLAY | Buy | RELAY THERAPEUTICS INC | $96,141,000 | +48.8% | 3,130,605 | +52.8% | 3.49% | +38.4% |
| CRNX | Buy | CRINETICS PHARMACEUTICALS IN | $85,340,000 | +325.0% | 3,003,879 | +214.9% | 3.10% | +295.7% |
| CGEM | Buy | CULLINAN ONCOLOGY INC | $82,851,000 | +399.4% | 5,369,459 | +630.4% | 3.01% | +364.8% |
| ARGX | Sell | ARGENX SEsponsored adr | $75,712,000 | -31.5% | 216,204 | -41.0% | 2.75% | -36.3% |
| XOMA | XOMA CORP DEL | $73,612,000 | -15.8% | 3,530,543 | 0.0% | 2.67% | -21.6% | |
| OLMA | Buy | OLEMA PHARMACEUTICALS INC | $69,372,000 | -62.2% | 7,411,503 | +11.3% | 2.52% | -64.8% |
| GLPG | Buy | GALAPAGOS NVspon adr | $63,752,000 | +8.2% | 1,156,393 | +3.3% | 2.31% | +0.7% |
| LXRX | LEXICON PHARMACEUTICALS INC | $56,578,000 | -18.1% | 14,360,000 | 0.0% | 2.05% | -23.8% | |
| AMRN | Buy | AMARIN CORP PLCspons adr new | $55,470,000 | -4.7% | 16,459,965 | +44.3% | 2.01% | -11.3% |
| New | EQRX INC | $53,603,000 | – | 7,859,670 | +100.0% | 1.95% | – | |
| SNDX | Sell | SYNDAX PHARMACEUTICALS INC | $45,963,000 | -3.3% | 2,099,714 | -15.6% | 1.67% | -10.0% |
| RVMD | Sell | REVOLUTION MEDICINES INC | $45,572,000 | -33.3% | 1,810,549 | -27.1% | 1.65% | -38.0% |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | $44,009,000 | -18.6% | 2,005,862 | 0.0% | 1.60% | -24.3% | |
| EPIX | ESSA PHARMA INC | $40,491,000 | +77.5% | 2,851,461 | 0.0% | 1.47% | +65.2% | |
| RAIN | RAIN THERAPEUTICS INC | $38,097,000 | -13.9% | 2,957,807 | 0.0% | 1.38% | -19.9% | |
| VRDN | Buy | VIRIDIAN THERAPEUTICS INC | $37,156,000 | +180.9% | 1,879,412 | +133.7% | 1.35% | +161.4% |
| RLMD | New | RELMADA THERAPEUTICS INC | $37,116,000 | – | 1,647,400 | +100.0% | 1.35% | – |
| VSTM | Buy | VERASTEM INC | $34,977,000 | -24.2% | 17,062,158 | +13.9% | 1.27% | -29.4% |
| ACIU | Buy | AC IMMUNE SA | $34,959,000 | -24.9% | 7,062,379 | +1.8% | 1.27% | -30.1% |
| KDNY | New | CHINOOK THERAPEUTICS INC | $29,358,000 | – | 1,800,000 | +100.0% | 1.07% | – |
| KURA | Buy | KURA ONCOLOGY INC | $28,899,000 | -5.6% | 2,064,212 | +26.2% | 1.05% | -12.2% |
| Buy | TYRA BIOSCIENCES INC | $26,358,000 | -11.6% | 1,873,332 | +10.5% | 0.96% | -17.7% | |
| SPRO | Sell | SPERO THERAPEUTICS INC | $25,386,000 | -23.8% | 1,585,615 | -12.4% | 0.92% | -29.2% |
| CTMX | New | CYTOMX THERAPEUTICS INC | $25,130,000 | – | 5,803,700 | +100.0% | 0.91% | – |
| REPL | REPLIMUNE GROUP INC | $25,109,000 | -8.6% | 926,529 | 0.0% | 0.91% | -14.9% | |
| ACRS | Buy | ACLARIS THERAPEUTICS INC | $24,658,000 | -0.2% | 1,695,904 | +23.5% | 0.90% | -7.2% |
| IKNA | Sell | IKENA ONCOLOGY INC | $22,552,000 | -2.5% | 1,798,371 | -1.8% | 0.82% | -9.2% |
| CTIC | CTI BIOPHARMA CORP | $22,146,000 | -15.9% | 8,929,690 | 0.0% | 0.80% | -21.8% | |
| ALPN | ALPINE IMMUNE SCIENCES INC | $22,015,000 | +29.8% | 1,589,495 | 0.0% | 0.80% | +20.7% | |
| Sell | AADI BIOSCIENCES INC | $21,720,000 | -35.5% | 899,392 | -21.6% | 0.79% | -40.0% | |
| OVID | OVID THERAPEUTICS INC | $21,286,000 | -4.5% | 6,631,051 | 0.0% | 0.77% | -11.0% | |
| PIRS | PIERIS PHARMACEUTICALS INC | $20,141,000 | -26.9% | 5,328,239 | 0.0% | 0.73% | -32.0% | |
| JANX | JANUX THERAPEUTICS INC | $20,072,000 | -8.8% | 1,017,314 | 0.0% | 0.73% | -15.1% | |
| New | PYXIS ONCOLOGY INC | $19,651,000 | – | 1,791,351 | +100.0% | 0.71% | – | |
| CALT | CALLIDITAS THERAPEUTICS ABsponsered ads | $18,570,000 | +14.5% | 750,000 | 0.0% | 0.67% | +6.5% | |
| NGM | NGM BIOPHARMACEUTICALS INC | $16,913,000 | -15.7% | 955,000 | 0.0% | 0.61% | -21.6% | |
| PNT | Buy | POINT BIOPHARMA GLOBAL INC | $16,355,000 | -23.3% | 2,920,526 | +5.3% | 0.59% | -28.6% |
| SLN | SILENCE THERAPEUTICS PLCads | $15,600,000 | +8.2% | 666,666 | 0.0% | 0.57% | +0.7% | |
| INFI | Sell | INFINITY PHARMACEUTICALS INC | $14,296,000 | -50.1% | 6,353,645 | -24.2% | 0.52% | -53.6% |
| STRO | Buy | SUTRO BIOPHARMA INC | $13,766,000 | -11.9% | 925,148 | +11.9% | 0.50% | -17.9% |
| GLYC | GLYCOMIMETICS INC | $13,744,000 | -34.2% | 9,544,262 | 0.0% | 0.50% | -38.8% | |
| DAWN | Sell | DAY ONE BIOPHARMACEUTICALS I | $13,636,000 | -29.1% | 809,282 | -0.1% | 0.50% | -34.0% |
| COGT | COGENT BIOSCIENCES INC | $13,147,000 | +2.0% | 1,532,282 | 0.0% | 0.48% | -5.2% | |
| VIRX | Buy | VIRACTA THERAPEUTICS INC | $12,552,000 | -49.4% | 3,438,944 | +11.1% | 0.46% | -52.9% |
| MTEM | Buy | MOLECULAR TEMPLATES INC | $12,268,000 | -36.0% | 3,129,599 | +9.6% | 0.44% | -40.5% |
| CFRX | CONTRAFECT CORP | $10,447,000 | -35.1% | 3,972,300 | 0.0% | 0.38% | -39.6% | |
| ELEV | Buy | ELEVATION ONCOLOGY INC | $9,702,000 | -21.7% | 1,611,698 | +1.3% | 0.35% | -27.1% |
| MEIP | MEI PHARMA INC | $9,431,000 | -3.3% | 3,532,057 | 0.0% | 0.34% | -10.0% | |
| CDTX | Buy | CIDARA THERAPEUTICS INC | $8,714,000 | -18.6% | 6,861,127 | +43.6% | 0.32% | -24.2% |
| NUVALENT INC | $8,540,000 | -15.6% | 448,512 | 0.0% | 0.31% | -21.5% | ||
| MOLN | Buy | MOLECULAR PARTNERS AGads | $8,550,000 | +3.4% | 443,221 | +5.8% | 0.31% | -4.0% |
| IVA | INVENTIVA SAads | $7,438,000 | -3.5% | 544,500 | 0.0% | 0.27% | -10.3% | |
| CNCE | New | CONCERT PHARMACEUTICALS INC | $7,097,000 | – | 2,253,000 | +100.0% | 0.26% | – |
| MIRM | MIRUM PHARMACEUTICALS INC | $6,953,000 | -19.9% | 435,936 | 0.0% | 0.25% | -25.7% | |
| ELDN | Buy | ELEDON PHARMACEUTICALS INC | $6,077,000 | -27.9% | 1,378,020 | +1.1% | 0.22% | -32.8% |
| SELB | Buy | SELECTA BIOSCIENCES INC | $5,617,000 | +322.3% | 1,723,133 | +439.0% | 0.20% | +292.3% |
| CNTA | New | CENTESSA PHARMACEUTICALS PLCsponsored ads | $5,118,000 | – | 454,545 | +100.0% | 0.19% | – |
| EUCRU | EUCRATES BIOMEDICAL ACQU CORunit 10/23/2027 | $4,990,000 | +0.7% | 500,000 | 0.0% | 0.18% | -6.2% | |
| CALA | CALITHERA BIOSCIENCES INC | $4,957,000 | -69.5% | 7,452,331 | 0.0% | 0.18% | -71.6% | |
| FLACU | FRAZIER LIFESCIENCES ACQU COunit 12/09/2025 | $4,950,000 | +0.4% | 500,000 | 0.0% | 0.18% | -6.2% | |
| FVAM | 5 01 ACQUISITION CORP | $4,925,000 | +0.5% | 500,000 | 0.0% | 0.18% | -6.3% | |
| RACB | RESEARCH ALLIANCE CORP II | $4,860,000 | +0.6% | 500,000 | 0.0% | 0.18% | -6.4% | |
| GNCA | GENOCEA BIOSCIENCES INC | $4,654,000 | -39.6% | 4,012,404 | 0.0% | 0.17% | -43.9% | |
| CRVS | CORVUS PHARMACEUTICALS INC | $3,304,000 | -50.2% | 1,370,947 | 0.0% | 0.12% | -53.7% | |
| GLMD | GALMED PHARMACEUTICALS LTD | $3,275,000 | -34.8% | 1,799,694 | 0.0% | 0.12% | -39.3% | |
| ERYP | ERYTECH PHARMAsponsored adr | $3,103,000 | -59.1% | 1,314,656 | 0.0% | 0.11% | -61.8% | |
| ANGN | ANGION BIOMEDICA CORP | $3,107,000 | -70.3% | 1,071,297 | 0.0% | 0.11% | -72.3% | |
| ALRN | AILERON THERAPEUTICS INC | $2,964,000 | -44.8% | 5,265,555 | 0.0% | 0.11% | -48.6% | |
| JYAC | JIYA ACQUISITION CORP | $2,931,000 | -0.1% | 300,000 | 0.0% | 0.11% | -7.0% | |
| FWP | FORWARD PHARMA A/Ssponsord ads new | $2,584,000 | -13.5% | 432,892 | 0.0% | 0.09% | -19.7% | |
| ABOS | ACUMEN PHARMACEUTICALS INC | $1,958,000 | -54.5% | 289,663 | 0.0% | 0.07% | -57.7% | |
| XFOR | X4 PHARMACEUTICALS INC | $1,942,000 | -56.7% | 847,879 | 0.0% | 0.07% | -60.0% | |
| GBIO | New | GENERATION BIO CO | $1,338,000 | – | 189,050 | +100.0% | 0.05% | – |
| New | BIONOMICS LIMITEDads | $1,016,000 | – | 80,971 | +100.0% | 0.04% | – | |
| RZLT | REZOLUTE INC | $912,000 | -35.6% | 190,815 | 0.0% | 0.03% | -40.0% | |
| VYGR | New | VOYAGER THERAPEUTICS INC | $60,000 | – | 22,200 | +100.0% | 0.00% | – |
| ANAB | Exit | ANAPTYSBIO INC | $0 | – | -334,398 | -100.0% | -0.35% | – |
| GRTS | Exit | GRITSTONE BIO INC | $0 | – | -1,528,072 | -100.0% | -0.64% | – |
| Exit | MERUS N V | $0 | – | -5,060,071 | -100.0% | -4.34% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| XENON PHARMACEUTICALS INC | 36 | Q3 2023 | 4.7% |
| PIERIS PHARMACEUTICALS INC | 30 | Q3 2023 | 2.8% |
| CYTOKINETICS INC | 29 | Q4 2020 | 11.8% |
| INFINITY PHARMACEUTICALS INC | 29 | Q2 2023 | 4.3% |
| XOMA CORP DEL | 28 | Q3 2023 | 7.3% |
| ARQULE INC | 27 | Q4 2019 | 4.8% |
| CHEMOCENTRYX INC | 26 | Q3 2019 | 13.8% |
| CYTOMX THERAPEUTICS INC | 26 | Q3 2023 | 5.3% |
| CORVUS PHARMACEUTICALS INC | 26 | Q3 2023 | 2.3% |
| ARRAY BIOPHARMA INC | 25 | Q2 2019 | 14.5% |
View BVF INC/IL's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 4 | 2024-01-29 |
| 3 | 2024-01-26 |
| 4 | 2024-01-09 |
| 4 | 2023-12-20 |
| 4 | 2023-11-17 |
| 13F-HR | 2023-11-14 |
| 3 | 2023-11-13 |
| 3 | 2023-11-06 |
| 4 | 2023-11-06 |
View BVF INC/IL's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.